Tamang Anand, Tamang Jyotsna
Center for Research on Environment Health and Population Activities (CREHPA), Kathmandu, Nepal.
Reprod Health Matters. 2005 Nov;13(26):110-9. doi: 10.1016/S0968-8080(05)26194-3.
Abortion was legalised in Nepal in September 2002 and manual vacuum aspiration is the main procedure used for safe abortion. Although medical abortion has not yet officially been introduced in Nepal, with the highly porous Indo-Nepal border and the easy availability of mifepristone and misoprostrol in Indian chemists' shops, it is possible the drugs are entering from Indian markets illegally. This study aimed to gauge current awareness of the availability of medical abortion drugs in Nepal and explore what health professionals and paramedics felt about the use of medical abortion to expand access to safe abortion in the country. Data were drawn from interviews with private obstetrician-gynaecologists, general physicians, paramedics, ayurvedic and homeopathic practitioners and chemists in 24 urban municipalities and peri-urban areas in Nepal. Various types of allopathic and indigenous forms of medicine for menstrual regulation in the Nepalese market were widely known whereas knowledge of the availability of mifepristone and misoprostrol was low. Almost all respondents had a positive view of the potential for providing mifepristone and misoprostol in Nepal and most thought that obstetrician-gynaecologists, general physicians and other certified abortion care providers should be able to provide the drugs. Many respondents were interested in doing so themselves. Registration of mifepristone and misoprostrol is the key to introducing medical abortion in Nepal and should happen as soon as possible.
2002年9月,尼泊尔将堕胎合法化,人工负压吸引术是安全堕胎的主要方法。尽管尼泊尔尚未正式引入药物流产,但由于印尼边境管控不严,且在印度药店米非司酮和米索前列醇很容易买到,这些药物有可能正从印度市场非法流入尼泊尔。本研究旨在评估尼泊尔目前对药物流产药物可获得性的认知情况,并探讨卫生专业人员和辅助医务人员对使用药物流产以扩大该国安全堕胎途径的看法。数据来自对尼泊尔24个城市和城郊地区的私立妇产科医生、普通医生、辅助医务人员、阿育吠陀和顺势疗法从业者以及药剂师的访谈。尼泊尔市场上各种对抗疗法和本土形式的月经调节药物广为人知,而对米非司酮和米索前列醇可获得性的了解却很少。几乎所有受访者都对在尼泊尔提供米非司酮和米索前列醇的可能性持积极态度,大多数人认为妇产科医生、普通医生和其他有资质的堕胎护理提供者应该能够提供这些药物。许多受访者自己也有兴趣这样做。米非司酮和米索前列醇的注册是在尼泊尔引入药物流产的关键,应尽快进行。